- Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro
Sarah E. Kohrt et al, 2021, Molecular Cancer Therapeutics CrossRef - Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro
Karol Bukowski et al, 2022, Molecules CrossRef - An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
Azmi Yerlikaya et al, 2020, Cytotechnology CrossRef - The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor
Kenji Kuroda et al, 2019, International Journal of Oncology CrossRef - Nell‐1‐ΔE, a novel transcript of Nell‐1, inhibits cell migration by interacting with enolase‐1
Huaxiang Zhao et al, 2018, Journal of Cellular Biochemistry CrossRef - Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
Fei Feng et al, 2017, Cancer Biology & Therapy CrossRef - Cytotoxic urea Schiff base complexes for multidrug discovery as anticancer activity and low in vivo oral assessing toxicity
Lotfi M. Aroua et al, 2022, Arabian Journal of Chemistry CrossRef - Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactions
Jannick Clemens et al, 2017, Oncology Letters CrossRef - The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Azmi Yerlikaya et al, 2020, Current Drug Targets CrossRef - Synthesis, characterization, and anticancer activity of some metal complexes with a new Schiff base ligand
Thamer A. Alorini et al, 2022, Arabian Journal of Chemistry CrossRef - Investigations into the therapeutic potential of Asphodeline liburnica roots: In vitro and in silico biochemical and toxicological perspectives
Marcello Locatelli et al, 2018, Food and Chemical Toxicology CrossRef - The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Di Zhang et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef - Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
Şükrü Aydın Düzgün et al, 2017, Cytotechnology CrossRef - PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance
Zhenrui Fu et al, 2019, Anti-Cancer Drugs CrossRef - Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway
Bin Huang et al, 2019, Technology in Cancer Research & Treatment CrossRef - Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
Nicholas Sciascia et al, 2020, eLife CrossRef - A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis
Emrah Okur et al, 2019, Cell Biology and Toxicology CrossRef - Anticancer, antimicrobial, and DNA protection analysis of novel 2,4-dihydroxyquinoline dyes
Nesrin Şener et al, 2018, Dyes and Pigments CrossRef - Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer
Nirmish Singla et al, 2019, Expert Opinion on Investigational Drugs CrossRef - P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors
Andressa Barban do Patrocinio et al, 2022, ACS Omega CrossRef - Elaboration of novel urea bearing schiff bases as potent in vitro anticancer candidates with low in vivo acute oral toxicity
Lotfi M. Aroua et al, 2022, Main Group Chemistry CrossRef - Novel water soluble Schiff base metal complexes: Synthesis, characterization, antimicrobial-, DNA cleavage, and anticancer activity
C. Shiju et al, 2020, Journal of Molecular Structure CrossRef